Massey K. serves as Chief Operating Officer of argenx SE, a biopharmaceutical company based in the Netherlands. As an executive subject to EU Market Abuse Regulation disclosure requirements, K. is obligated to report securities transactions. Two such regulated disclosures have been publicly filed.
Historique des transactions
0 transactions signalCôté
Aucune transaction déclarée trouvée.